Moneycontrol PRO
HomeNewsTrendsHospital oxygen plants not enough, India needs national medical oxygen grid: Report

Hospital oxygen plants not enough, India needs national medical oxygen grid: Report

The report backed by the US AID for International Development and Bill and Melinda Gates Foundation bats for a reliable national oxygen grid with multiple generation and storage components, and a network for a smooth flow from surplus to deficit areas.

October 20, 2022 / 10:04 IST
(Image: AP)

The government had gone on a mission mode to set up oxygen plants in hospitals after a severe shortage of the life-saving gas was blamed for a large number of deaths during the COVID-19 pandemic last year.

However, a report now says all notifications and regulations that necessitate new Pressure Swing Absorption (PSA) oxygen plants for medical colleges or hospitals should be withdrawn and instead a national oxygen grid set up.

The report titled 'Blueprint for the National Medical Oxygen Grid' by research organisation One Health Trust assessed the current mechanisms for the availability of medical oxygen in India and suggested ways to improve it.

The report, which has former National Health Authority executive director Indu Bhushan as one of the authors, has been supported by the US AID for International Development and Bill and Melinda Gates Foundation.

A total of 4,135 PSA plants have been established doubling the oxygen production capacity in the country since the devastating second wave of Covid-19, which killed lakhs of people across India, mainly due to oxygen shortage. Last year, the Centre made it mandatory for all new medical colleges to install a PSA plant within six months of getting operational.
Outlining the contours of the oxygen network, Ramanan Laxminarayanan, founder and president of One Health Trust, said it would be like an electricity grid, with central generation (liquid medical oxygen), transmission (tankers and cylinders), storage (liquid and gaseous) and decentralised production (pressure swing adsorption generators and oxygen concentrators).

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

No electricity grid would rely on just decentralised solar or micro-hydro plants without centralised transmission and distribution; similarly, a reliable national oxygen grid should have multiple generation and storage components, says the report.

The National Medical Oxygen Grid, if executed, will be a far-reaching endeavour that would unify the medical oxygen supply and consumption industry for efficient management of medical oxygen supply in the country, especially during health crises, the 144-page document said.

Also read | Rising COVID-19 cases and new Omicron subvariants put government on alert

Patients with severe Covid-19, which often causes acute respiratory distress syndrome, require immediate, high-purity oxygen without which their damaged lungs are unable to maintain blood oxygen levels.

Getting future-ready

The report said lack of utilisation of medical oxygen, especially outside of major metros, meant that there was both a lack of supply as well as personnel trained to use medical oxygen.

It is vital to fix the problem and ensure that oxygen is widely available and used in the farthest corners of the country during normal times so that the country’s infrastructure is ready for any future crisis, the report pointed out.

It recommended a four-step approach for the design of the grid, including modelling and planning exercises to forecast the demand that must be met, dividing demand into manageable distribution areas to ease distribution.
The third step, as per the report, would be to create a detailed supply-side assessment so that the demands may be met and the final step would be designing the grid network that would include detailed steady-state and exigency operational plans.

Some other features of the proposed grid would be the creation of a large storage reservoir capacity to meet any future demand spurt and an interconnected network allowing for a smooth flow from surplus to deficit areas.

According to senior biologist Dr Gagandeep Kang, who is associated with Christian Medical College, Vellore, the despair of April-May 2021 is rapidly being forgotten.

“This comprehensive report is a valuable tool that reviews potential demand, productive capacity and distribution mechanisms in order to ensure that data to form a strategy for a National Oxygen Grid are readily available to policymakers,” she said.

Oxygen crisis of 2021

During the second wave of the pandemic, the peak of medical oxygen sales, about 9,000 Metric-Tons-Per-Day (MTPD), were unable to meet about 17,000 MTPD needs.

In the pre-Covid-19 scenario, India had an absolute production capacity of approximately 10–11,000 MTPD of oxygen, which was sufficient to meet industrial (9,600-10,000 MTPD) and medical (1,000–1,400 MTPD) requirements.

However, a significant demand-supply gap in medical oxygen was witnessed during the pandemic when it failed to meet about 35 percent of the medical demand. The production capacity was also not uniformly distributed, with regional variations in supply and demand patterns.
After the frenzied pace of setting up oxygen plants, the absolute production capacity is now estimated to be 18–19,000 MTPD nationwide, although there is significant variation.

Also read | Coming Soon: Eye drops that can help you put away your reading glasses

Several oxygen production and supply initiatives have been adopted in India at both national and state levels.

These include short- and long-term policy measures, such as installing oxygen production plants (1,225 plants have been set up under the PM-CARES, another 336 PSA plants are from public sector undertakings, and about 2,574 PSA plants are being set up through the state and CSR funds), increasing production capacity in existing plants, and developing technology-enabled supply-demand management systems.

Sumi Sukanya Dutta
Sumi Sukanya Dutta
first published: Oct 20, 2022 10:04 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347